Expiring federal contract · order under a contract vehicle
75N93024F00002 — University Of Texas Medical Branch At Galveston
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N93024F00002
- Incumbent
- University Of Texas Medical Branch At Galveston
- Incumbent UEI
- MSPWVMXXMN76
- Current end date
- January 17, 2027
- Potential total value
- $3,270,971
- Obligated
- $3,270,971
- NAICS
- 541711 — Research and Development in Biotechnology
- PSC
- AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
- Set-aside
- SB-Total
- Start date
- June 25, 2024
- Place of performance
- TX
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
MODEL DEVELOPMENT AND MEDICAL COUNTER MEASURES (MCMS) FOR BSL-4 AGENTS IN NHPS.
Likely rebid window (estimate)
- Sources Sought / RFI: about Jan 2026 – Jul 2026 (6–12 months before the end date)
- RFP: about Sep 2026 – Nov 2026 (2–4 months before the end date)
In the final months before the current end date.
This is an order under contract vehicle HHSN272201700040I. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 541711)
- 75N93022F00001 — University Of North Carolina At Chapel Hill · ends November 30, 2026 · $1.7M
- 75N93019F00132 — The Emmes Company, LLC · ends December 31, 2026 · $174K
- HHSN27500007 — Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center · ends December 31, 2026 · $12M
- HHSO100201600017C — Dnae Group Holdings Limited · ends December 31, 2026 · $43M
- HHSO100201600009C — Cerus Corporation · ends March 31, 2027 · $185M
- 75N93019F00131 — University Of Alabama At Birmingham · ends April 30, 2027 · $8.8M
- HHSN275201700002C — The Emmes Company, LLC · ends May 28, 2027 · $66M
- 75N93024F00001 — Trustees Of Tufts College · ends July 10, 2027 · $823K
- HHSO100201700020C — Regeneron Pharmaceuticals INC · ends September 25, 2027 · $279M
- HHSO100201700012C — Merck Sharp & Dohme LLC · ends September 27, 2027 · $236M